Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Terry D. who wrote (3694)	5/8/2005 8:42:02 PM
From: Maurice Winn	Read Replies (1) \| Respond to of 3702

Hi Terry. It's nice that life has happy outcomes sometimes. The more the merrier. image.blog.livedoor.jp What a great scene. Tarken and girlfriend saw that in Canada. What's annoying is that Rituxan is now considered a useful adjunct therapy to intermediate grade NHL and I dare say Zevalin [or whatever it's now called is too]. But the medical guilds are too slow for too many people. Due process you know. Oncolym never made it and Cotara floundered around. Things should move faster. Much faster. Time is of the essence. Mqurice